CUMBERLAND PHARMACEUTICALS INC
CPIXUS売上高
$45M
百万USD
営業利益
$-3M
百万USD
純利益
$-3M
百万USD
ROE
-11.4%
最新FY
EPS
$-0.19
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $11M | $0M | $0.01 |
| FY2021 | Q2 | $9M | $1M | $0.08 |
| FY2021 | Q3 | $8M | $-1M | $-0.07 |
| FY2021 | FY | $35M | $-4M | $-0.24 |
| FY2022 | Q1 | $11M | $-1M | $-0.09 |
| FY2022 | Q2 | $10M | $-1M | $-0.09 |
| FY2022 | Q3 | $11M | $-0M | $-0.03 |
| FY2022 | FY | $41M | $-6M | $-0.38 |
| FY2023 | Q1 | $9M | $0M | - |
| FY2023 | Q2 | $11M | $1M | - |
| FY2023 | Q3 | $10M | $-1M | - |
| FY2023 | FY | $40M | $-6M | $-0.44 |
| FY2024 | Q1 | $8M | $-2M | $-0.14 |
| FY2024 | Q2 | $10M | $-1M | $-0.08 |
| FY2024 | Q3 | $9M | $-2M | $-0.11 |
| FY2024 | FY | $38M | $-6M | $-0.46 |
| FY2025 | Q1 | $9M | $-3M | $-0.22 |
| FY2025 | Q2 | $11M | $-1M | $-0.05 |
| FY2025 | Q3 | $8M | $-2M | $-0.13 |
| FY2025 | FY | $45M | $-3M | $-0.19 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $40M | $46M | $36M | $35M | $41M | $40M | $38M | $45M |
| 営業利益 | $-1M | $-4M | $-7M | $-4M | $-6M | $-8M | $-6M | $-10M | $-6M | $-3M |
| 純利益 | $-1M | $-8M | $-7M | $-4M | $-3M | $-4M | $-6M | $-6M | $-6M | $-3M |
| 総資産 | $93M | $93M | $113M | $105M | $96M | $84M | $93M | $82M | $76M | $77M |
| 純資産 | $73M | $64M | $56M | $51M | $47M | $43M | $36M | $29M | $23M | $25M |
| 自己資本 | $73M | $64M | $56M | $51M | $47M | $43M | $36M | $30M | $23M | $25M |
| 営業CF | $1M | $-1M | $3M | $3M | $5M | $6M | $8M | $6M | $-1M | $5M |
| EPS | $-0.06 | $-0.50 | $-0.45 | $-0.23 | $-0.22 | $-0.24 | $-0.38 | $-0.44 | $-0.46 | $-0.19 |
| BPS | $4.57 | $4.10 | $3.62 | $3.37 | $3.15 | $2.88 | $2.52 | $2.09 | $1.64 | $1.66 |
| ROE | -1.3% | -12.4% | -12.5% | -6.9% | -7.1% | -8.2% | -15.4% | -21.2% | -28.4% | -11.4% |